Does ERLOTINIB Cause Performance status decreased? 31 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 31 reports of Performance status decreased have been filed in association with ERLOTINIB (Erlotinib). This represents 0.1% of all adverse event reports for ERLOTINIB.
31
Reports of Performance status decreased with ERLOTINIB
0.1%
of all ERLOTINIB reports
13
Deaths
9
Hospitalizations
How Dangerous Is Performance status decreased From ERLOTINIB?
Of the 31 reports, 13 (41.9%) resulted in death, 9 (29.0%) required hospitalization, and 2 (6.5%) were considered life-threatening.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ERLOTINIB. However, 31 reports have been filed with the FAERS database.
What Other Side Effects Does ERLOTINIB Cause?
Death (5,000)
Rash (4,648)
Diarrhoea (3,448)
Fatigue (1,548)
Nausea (1,366)
Drug ineffective (1,207)
Off label use (1,190)
Decreased appetite (998)
Malignant neoplasm progression (954)
Dry skin (953)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
LUMATEPERONE (68)
Which ERLOTINIB Alternatives Have Lower Performance status decreased Risk?
ERLOTINIB vs ERTAPENEM
ERLOTINIB vs ERTUGLIFLOZIN PIDOLATE
ERLOTINIB vs ERYTHROMYCIN
ERLOTINIB vs ERYTHROMYCIN ETHYLSUCCINATE
ERLOTINIB vs ERYTHROMYCIN LACTOBIONATE